Morgan Stanley AIP GP LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Morgan Stanley AIP GP LP
CRD #117050
SEC #801-60699
CIK #0001230207
AUM 40.85 B (2026-03-30)
Employees 200 (84% Investors, 14% Brokers)
Fees
Minimum
Phone610-260-7600
Address100 Front Street
West Conshohocken, PA 19428
Source [IAPD] [EDGAR] [Website]
Total AUM ($B)
806448321601999200820172027
Fees and Compensation — Form ADV Part 2A (3/30/2026) [Brochure]
Item 5 Fees and Compensation

Hedge Funds and Opportunistic Investments
For advisory services rendered to Clients pursuing a hedge fund or opportunistic investment strategy, AIP is generally
entitled to a management fee in an amount (on an annualized basis) of up to (i) 1.50% of the net asset value of the
applicable Fund or SMA, or (ii) 1.50% of the aggregate capital commitment to the applicable Fund or SMA. In the case
of certain Funds, the fees charged by AIP may decrease over time upon the occurrence of certain events, as described
in the governing materials of such Funds or SMAs. In some cases, AIP or one of its affiliates is also entitled to receive
performance-based fees or allocations which may be up to 10% of the investor’s net profits and may be subject to a
minimum hurdle rate and/or high-water mark.
In addition, for certain Funds, an affiliate is generally entitled to carried interest with respect to each investor equal to
10% of such investor’s profits, subject to satisfaction of an 8% internal rate.
Funds pursuing a hedge funds or opportunistic investment strategy generally book fees (and as applicable, incentive
allocation estimates) on a monthly or quarterly basis.
AIP also charges a fee to MSSB for providing services related to (i) conducting investment and operational due diligence
on hedge funds; (ii) providing portfolio advisory services in connection with customized mandates; and (iii) managing a
list of hedge funds into which qualified advisory Wealth Management clients may invest.

Alternative Lending
For advisory services rendered to the Alternative Lending Fund, AIP is entitled to a management fee in an amount of
0.75% on an annualized basis of the Alternative Lending Fund’s Managed Assets. “Managed Assets” means the total
assets of the Alternative Lending Fund (including any assets attributable to borrowings for investment purposes) minus
the sum of the Alternative Lending Fund’s accrued liabilities (other than liabilities representing borrowings for investment
purposes).

Omni Strategy
For investment advisory services rendered to the Omni Fund, AIP is generally entitled to a management fee in an amount
(on an annualized basis) ranging from 0.00% to 2.00% of the net asset value of each Omni Fund investor’s capital
account.
AIP or an affiliate of AIP is generally entitled to an incentive allocation with respect to each investor in the Omni Fund
generally ranging from 0% to 20% of such investor’s profits, subject, with respect to certain series of interests, to
satisfaction of a hurdle rate of 4%.
The Omni Fund management fee is accrued monthly and payable quarterly in advance and is generally paid in arrears.
While AIP does not intend to cause the Omni Fund to terminate its investment management relationship with AIP absent
AIP’s reorganization, liquidation, or bankruptcy, the Omni Fund’s management fee will be prorated for partial periods.
In addition to the management fee and incentive allocation payable by the Omni Fund to AIP and its affiliates, the Omni
Fund will pay each Portfolio Manager an advisory fee and/or performance compensation based on the performance
results achieved with respect to the Omni Fund’s investments managed by such Portfolio Manager. The Omni Fund
may also pay a portion of a Portfolio Manager’s expenses (including expenses incurred in connection with its entering
into an agreement with the Omni Fund) or pay certain advisory fees and performance compensation to the Portfolio
Manager in advance. The Omni Fund may also pay one or more Portfolio Managers a guaranteed amount of advisory
fees or expenses, which the Omni Fund would be required to pay even if AIP or the Omni Fund terminated the agreement
with the applicable Portfolio Manager (“Portfolio Manager Agreement”) prior to a specified date. Any payments made or
required to be made to, or in respect of, Portfolio Managers in connection with their management of the Omni Fund’s

FORM ADV, PART 2A BROCHURE                                                                    MORGAN STANLEY AIP GP LP      7

capital, including advisory fees, performance compensation and other payments, as well as payments made to AIP or
its affiliates relating to Internal Portfolio Managers, are collectively referred to as “Trader Payouts.”

Private Markets
For investment advisory services rendered to the Funds pursuing a Private Markets investment strategy, AIP is
occasionally entitled to a flat fee and more generally entitled to a management fee during the investment period in an
amount (on an annualized basis) of up to 1.75% of either (i) the investor’s aggregate capital commitment to the Fund (ii)
the investor’s attributable share of the aggregate capital commitments made by the Fund to its Underlying Investment
Funds (based on the acquisition costs of such investments); (iii) the investor’s attributable share of the aggregate capital
contributions made by the Fund to its Underlying Investment Funds (excluding amounts constituting a return of a capital
contribution by such underlying investments); or (iv) the investor’s aggregate contributions with respect to Underlying
Investment Funds plus the investor’s attributable share of the aggregate unfunded capital commitments made by the
applicable Fund to its Underlying Investment Funds. In the case of certain Funds, the fees charged by AIP may decrease
over time after the investment period ends, as described in the governing materials of such Funds.
For funds that pursue a Private Markets strategy, the management fee will be charged in addition to an investor’s capital
commitment. In most cases, AIP or one of its affiliates is also entitled to receive performance-based fees, which vary.
AIP or an affiliate of AIP is generally entitled to carried interest with respect to each investor generally ranging from 5%
- 15% of such investor’s profits, subject to satisfaction of an internal rate of return ranging from 6% - 15%, compounded
annually.
...
Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2026) [Brochure]
Item 7 Types of Clients
AIP generally provides investment advice to registered and unregistered investment companies, pooled investment
vehicles, separate accounts, funds of one, corporate/business entities, high net worth individuals, endowments,
foundations, charitable institutions, sovereign wealth funds, foreign regulated funds such as UCITs, pension plans,
insurance companies and domestic and foreign government agencies, and trusts. In addition, AIP, through its Hedge
Fund Solutions business, provides investment research and operational due diligence services to MSSB, as previously
discussed in Item 4.
Investors who wish to participate in Funds are generally required to invest a certain minimum amount, which generally
ranges (depending on the Fund) from $25,000 to $50 million. Certain Funds may have additional minimum investment
requirements and may require that an investor is, among other things, an “accredited investor”, as defined under the
Securities Act of 1933 (the “1933 Act”), as amended, and the applicable rules promulgated by the SEC thereunder,
and/or a “qualified purchaser”, as defined under the Investment Company Act of 1940, as amended, and the applicable
rules promulgated by the SEC thereunder (the “1940 Act”).
The minimum account size for a separately managed account is negotiated on a case-by-case basis.
Generally, a minimum amount of $25 million is required if a Wealth Management client wishes to engage AIP in
connection with a customized portfolio account solution.

FORM ADV, PART 2A BROCHURE                                                              MORGAN STANLEY AIP GP LP   13
Sector Form 13F Holdings Value ($T)
Apple Inc 0.1
Nvidia Corp 0.1
Microsoft Corp 0.0
Amazon Com Inc 0.0
Alphabet Inc 0.0
Broadcom Inc 0.0
Facebook Inc 0.0
Alphabet Inc 0.0
J P Morgan Chase & Co 0.0
Tesla Motors Inc 0.0
View All
Holdings by Sector ($T)
4.03.22.41.60.80.02011201620212027
Type Form D Funds Date Sold AUM
Other Hedge Fund Core Primaries Series 1 A Series of Riverview Multi-Client Solutions Fund LP [2026-03-30] 89.5 M 96.1 M
Filed 2026-01-16 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
Other Montserrat Fund Cayman LP 2026-03-30 53.5 M
Other Orion Private Equity Partners Fund LP [2026-03-30] 11.0 M
Filed 2025-04-14 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
Other Riverview Alpha Strategies Q AIV LP 2026-03-30 204.7 M
Other Riverview Alpha Strategies Q LP 2026-03-30 374.0 M
Other Tandem SPV LP 2026-03-30 127.8 M
PE 1GT Fund LP [2025-03-28] 25.7 M
Filed 2023-12-15 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $750,000 · Net Assets Decline to Disclose
Other North Haven Ashbridge Co-Investment Opportunity B LP [2025-03-28] 64.1 M
Filed 2024-10-04 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
Other North Haven Private Equity Co-Investment Opportunities Fund III Splitter Lux SCSP [2025-03-28] 87.6 M
Filed 2024-05-15 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $225,000 · Net Assets Decline to Disclose
Other PSG Private Credit LP [2025-03-28] 300.6 M 71.7 M
Filed 2024-07-18 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 16 0.5
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 4 2.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 124 32.4
(g) Pension and profit sharing plans 4 0.8
(h) Charitable organizations 8 0.2
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 2 0.0
(k) Insurance companies 1 0.7
(l) Sovereign wealth funds and foreign official institutions 3 0.3
(m) Corporations or other businesses not listed above 36 4.0
(n) Other 1 0.0
Total 199 40.9
By Discretionary
Discretionary 184 40.1
Non-Discretionary 15 0.8
Total 199 40.9
By Non-United States Persons
Non-United States Persons 14.9
United States Persons 25.9
Total 199 40.9
Form D Directors Role # Filings # Firms 2011 - 2026
Charles Thomas Director 160 30
Campbell Congdon Director 179 28
Jason Sneah Director, Executive Officer 189 25
Tim Woolaver Director 90 25
Khalid Iton Director, Executive Officer 109 22
Peter Huber Director 88 22
Sam Ellis Director 106 18
Wendy Zhang Director 46 15
David Miller Director 298 14
Stephane Lachance Director 143 14
View All
EDGAR Form CIK 2011 - 2026
13F-NT [0001230207]
3 [0001230207]
4 [0001230207]
Firm Profile (Form ADV)
Discretionary AUM$4.9B
ServesInstitutional, Retail
Fund TypesHedge Fund, Private Equity, Real Estate
LEI549300KSRL5W75JNE398
Related People Network
206 people file Form D offerings alongside this firm's people, tied to 24 other firms through shared filers.
Form 3/4/5 Subject 2011 - 2026
Morgan Stanley AIP GP LP
North Haven Private Assets Fund
Morgan Stanley Investment Management Inc
Sagent Pharmaceuticals Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Sagent Pharmaceuticals Inc SGNT
Common Stock
2015-01-27 Sell 50,000 $26.19 1,309,500
Sagent Pharmaceuticals Inc SGNT
Common Stock
2015-01-26 Sell 28,041 $26.12 732,431
Sagent Pharmaceuticals Inc SGNT
Common Stock
2015-01-23 Sell 61,883 $25.90 1,602,770
Sagent Pharmaceuticals Inc SGNT
Common Stock
2015-01-22 Sell 150,000 $25.49 3,823,500
Sagent Pharmaceuticals Inc SGNT
Common Stock
2015-01-21 Sell 44,316 $25.22 1,117,650
Sagent Pharmaceuticals Inc SGNT
common stock
2015-01-20 Sell 25,000 $25.24 631,000
Sagent Pharmaceuticals Inc SGNT
Common Stock
2015-01-16 Sell 50,000 $25.26 1,263,000
Sagent Pharmaceuticals Inc SGNT
Common Stock
2015-01-15 Sell 75,000 $25.10 1,882,500
Sagent Pharmaceuticals Inc SGNT
Common Stock
2015-01-14 Sell 50,000 $25.53 1,276,500
Sagent Pharmaceuticals Inc SGNT
Common Stock
2015-01-13 Sell 50,000 $25.49 1,274,500
Sagent Pharmaceuticals Inc SGNT
Common Stock
2013-10-03 Sell 47,826 $20.27 969,433
Sagent Pharmaceuticals Inc SGNT
Common Stock
2013-10-02 Sell 40,020 $20.32 813,206
Sagent Pharmaceuticals Inc SGNT
Common Stock
2013-10-01 Sell 50,000 $20.70 1,035,000
Sagent Pharmaceuticals Inc SGNT
common stock
2013-09-30 Sell 28,872 $20.46 590,721
Sagent Pharmaceuticals Inc SGNT
common stock
2013-09-30 Sell 25,000 $20.38 509,500
Sagent Pharmaceuticals Inc SGNT
common stock
2013-09-27 Sell 10,000 $20.60 206,000
Sagent Pharmaceuticals Inc SGNT
common stock
2013-09-27 Sell 31,300 $20.52 642,276
Sagent Pharmaceuticals Inc SGNT
common stock
2013-09-26 Sell 67,965 $20.37 1,384,447
Sagent Pharmaceuticals Inc SGNT
common stock
2013-09-25 Sell 33,431 $21.22 709,406
Sagent Pharmaceuticals Inc SGNT
common stock
2013-09-24 Sell 14,693 $21.50 315,900
showing 20 of 24 most recent transactions
Related Firms State AUM
Morgan Stanley Smith Barney LLC
NY 1,961.89 B
Morgan Stanley Investment Management Inc
NY 702.25 B
Morgan Stanley Investment Management Limited
174.54 B
Morgan Stanley AIP GP LP
PA 40.85 B
MS Capital Partners Adviser Inc
NY 38.76 B
Morgan Stanley Infrastructure Inc
NY 15.97 B
MSREF Real Estate Advisor Inc
NY 15.77 B
Morgan Stanley Investment Management Company
10.94 B
Morgan Stanley Private Equity Asia Inc
NY 1,864.3 M
MSRESS III Manager LLC
NY 39.6 M
Morgan Stanley Smith Barney Venture Services LLC
NY
MSREF V LLC
NY
Morgan Stanley Real Estate Advisor Inc
NY
Comparable Firms State AUM
Mai Capital Management LLC
OH 52.10 B
SCS Capital Management LLC
MA 48.65 B
Abrdn Inc
PA 41.48 B
Strategic Investment Management LLC
VA 35.51 B
Luther King Capital Management Corporation
TX 31.50 B
Tiedemann Advisors LLC
NY 31.01 B
Waverly Advisors LLC
AL 29.78 B
Oxford Financial Group Ltd LLC
IN 23.33 B
Jordan Park Group LLC
CA 23.26 B
Ehrenkranz Partners LP
NY 21.54 B
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com